Table 1.
Age, gender, tumor site, treatment (RT = radiotherapy, CRT = chemoradiotherapy) and stimulated salivary secretion rate (ml/min) pre-treatment and six months post-treatment for the cancer patients and age, gender, stimulated salivary secretion rate (ml/min) for the healthy matched controls.
Patient |
Cancer patients |
Healthy controls |
|||||||
---|---|---|---|---|---|---|---|---|---|
Age |
Gender | Tumor |
Treatment | Secretion rate |
Age |
Gender | Secretion rate | ||
(years) | Site | Pre-treatment | 6 mo post treatment | (years) | |||||
P1 | 61 | F | Tonsil | CRT | 0.8 | 0.3 | 62 | F | 2.5 |
P2 | 51 | F | Tonsil | RT | 2.2 | 2.2 | 48 | F | 3.0 |
P3 | 76 | F | Tonsil | RT | 1.8 | 1.0 | 72 | F | 3.0 |
P4 | 55 | M | Tongue base | RT | 2.2 | 1.2 | 58 | M | 1.3 |
P5 | 63 | M | Tongue base | CRT | 1.0 | 0.5 | 59 | M | 3.2 |
Mean ± SD | 61 ± 10 | 1.6 ± 0.7 | 1.3 ± 1.2 | 60 ± 9 | 2.6 ± 0.8 |